Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
Immuncell-LC (GCC4002)
i
Other names:
GCC4002, Inno-LC-01
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
GC Biopharma, Rivaara Immune
Drug class:
T-cell stimulant
Related drugs:
‹
TC-210 (7)
BRG01 (1)
SAR443216 (1)
CDX 1127 (1)
23ME-00610 (0)
ABIO-0501 (0)
ADG138 (0)
ADXS-503 (0)
AGX-148 (0)
naptumomab estafenatox (0)
BPT-143 (0)
BS006 (0)
Bria-OTS (0)
CD30 biAb-AATC (0)
CDR101 (0)
CER-1236 (0)
GEN-001 (0)
GIM-122 (0)
GX301 (0)
HJ-N-001 (0)
JANX008 (0)
KROS-201 (0)
KSH01 (0)
MP0533 (0)
NEO_PLIN2101 (0)
NX-1607 (0)
PM3023 (0)
RPTR-147:1 (0)
SCG101 (0)
SMART 101 (0)
TAC100-HER2 (0)
TC-510 (0)
TCRT-ESO-A2 (0)
tabelecleucel (0)
UMG2-CD3 BTCE (0)
CF33-hNIS (0)
IRX-2 (0)
pTTL (0)
TC-210 (7)
BRG01 (1)
SAR443216 (1)
CDX 1127 (1)
23ME-00610 (0)
ABIO-0501 (0)
ADG138 (0)
ADXS-503 (0)
AGX-148 (0)
naptumomab estafenatox (0)
BPT-143 (0)
BS006 (0)
Bria-OTS (0)
CD30 biAb-AATC (0)
CDR101 (0)
CER-1236 (0)
GEN-001 (0)
GIM-122 (0)
GX301 (0)
HJ-N-001 (0)
JANX008 (0)
KROS-201 (0)
KSH01 (0)
MP0533 (0)
NEO_PLIN2101 (0)
NX-1607 (0)
PM3023 (0)
RPTR-147:1 (0)
SCG101 (0)
SMART 101 (0)
TAC100-HER2 (0)
TC-510 (0)
TCRT-ESO-A2 (0)
tabelecleucel (0)
UMG2-CD3 BTCE (0)
CF33-hNIS (0)
IRX-2 (0)
pTTL (0)
›
Associations
News
Trials
Filter by
Latest
4ms
Retrospective Study of Long-Term Survival of "Immuncell-LC" in Patients Undergoing Curative Resection for HCC in Korea (clinicaltrials.gov)
P=N/A, N=230, Completed, GC Cell Corporation | Not yet recruiting --> Completed
4 months ago
Trial completion
|
Immuncell-LC (GCC4002)
1year
Retrospective Study of Long-Term Survival of "Immuncell-LC" in Patients Undergoing Curative Resection for HCC in Korea (clinicaltrials.gov)
P=N/A, N=230, Not yet recruiting, GC Cell Corporation
1 year ago
New trial
|
Immuncell-LC (GCC4002)
over2years
Evaluate the Efficacy and Safety of 'Immuncell-LC' in Patients Undergoing Liver Transplantation (clinicaltrials.gov)
P1/2, N=19, Completed, GC Cell Corporation | Recruiting --> Completed | Trial completion date: Mar 2023 --> Aug 2022
over 2 years ago
Trial completion • Trial completion date • Immune cell
|
Immuncell-LC (GCC4002)
over2years
Safety and Efficacy of "Immuncell-LC" in TACE Therapy (clinicaltrials.gov)
P2, N=76, Completed, GC Cell Corporation | Active, not recruiting --> Completed
over 2 years ago
Trial completion • Immune cell
|
Immuncell-LC (GCC4002)
Share via
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.